Nicholas Investment Partners’s Cidara Therapeutics CDTX Stock Holding History

Nicholas Investment Partners’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,375	Closed	-$525K	–	210
2025 Q4	$525K	Buy	+2,375	New	+$384K	0.04%	197

Nicholas Investment Partners's CDTX Position: Q1 2026 in Review

Nicholas Investment Partners sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 2,375 shares — an estimated $525K sold.

Nicholas Investment Partners first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $525K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Nicholas Investment Partners reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Nicholas Investment Partners sold 2,375 Cidara Therapeutics shares in Q1 2026, an estimated $525K.
Nicholas Investment Partners first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Nicholas Investment Partners's Cidara Therapeutics position peaked at $525K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Nicholas Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.